Cemtrex Financials
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Cemtrex has an operating margin of 0.7%, meaning the company retains $1 of operating profit per $100 of revenue. This below-average margin results in a low score of 3/100, suggesting thin profitability after operating expenses. This is up from -7.9% the prior year.
Cemtrex's revenue grew 14.4% year-over-year to $76.5M, a solid pace of expansion. This earns a growth score of 70/100.
Cemtrex carries a low D/E ratio of 0.53, meaning only $0.53 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 92/100, indicating a strong balance sheet with room for future borrowing.
Cemtrex's current ratio of 1.22 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 29/100, which could limit financial flexibility.
While Cemtrex generated $159K in operating cash flow, capex of $1.9M consumed most of it, leaving -$1.8M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Cemtrex scores -0.95, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($12.6M) relative to total liabilities ($39.1M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Cemtrex passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Cemtrex generates $-0.01 in operating cash flow ($159K OCF vs -$28.1M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Cemtrex earns $0.2 in operating income for every $1 of interest expense ($510K vs $2.1M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
This page shows Cemtrex (CETX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Key Financial Metrics
Cemtrex generated $76.5M in revenue in fiscal year 2025. This represents an increase of 14.4% from the prior year.
Cemtrex's EBITDA was $1.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 147.3% from the prior year.
Cemtrex generated -$1.8M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 66.2% from the prior year.
Cemtrex reported -$28.1M in net income in fiscal year 2025. This represents a decrease of 288.9% from the prior year.
Cemtrex earned $-210.88 per diluted share (EPS) in fiscal year 2025. This represents an increase of 21.7% from the prior year.
Cemtrex held $5.0M in cash against $4.6M in long-term debt as of fiscal year 2025.
Cemtrex had 830,606 shares outstanding in fiscal year 2025. This represents an increase of 87701.9% from the prior year.
Cemtrex's gross margin was 42.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.1 percentage points from the prior year.
Cemtrex's operating margin was 0.7% in fiscal year 2025, reflecting core business profitability. This is up 8.5 percentage points from the prior year.
Cemtrex's net profit margin was -36.8% in fiscal year 2025, showing the share of revenue converted to profit. This is down 25.9 percentage points from the prior year.
Cemtrex invested $2.4M in research and development in fiscal year 2025. This represents a decrease of 29.9% from the prior year.
Cemtrex invested $1.9M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 48.9% from the prior year.
CETX Income Statement
| Metric | Q3'25 | Q2'25 | Q1'24 | Q3'24 | Q2'24 | Q1'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.0M-37.7% | $27.3M+98.3% | $13.7M-6.4% | $14.7M-14.4% | $17.2M+1.7% | $16.9M+14.6% | $14.7M-8.4% | $16.1M |
| Cost of Revenue | $9.6M-36.4% | $15.1M+87.7% | $8.0M-8.8% | $8.8M-13.8% | $10.2M+4.3% | $9.8M+18.7% | $8.2M-5.6% | $8.7M |
| Gross Profit | $7.4M-39.4% | $12.2M+113.4% | $5.7M-3.0% | $5.9M-15.3% | $6.9M-2.0% | $7.1M+9.3% | $6.5M-11.7% | $7.3M |
| R&D Expenses | $387K-50.3% | $778K-12.6% | $890K+3.0% | $864K-9.1% | $951K+12.1% | $849K-19.2% | $1.0M-35.0% | $1.6M |
| SG&A Expenses | $7.3M+13.2% | $6.5M-4.4% | $6.8M-14.1% | $7.9M+17.1% | $6.7M+1.7% | $6.6M+28.8% | $5.1M+0.3% | $5.1M |
| Operating Income | -$642K-113.9% | $4.6M+302.4% | -$2.3M+28.2% | -$3.2M-208.1% | -$1.0M-39.8% | -$738K-1473.1% | $54K-86.7% | $405K |
| Interest Expense | $462K+1.9% | $453K-6.4% | $484K-7.2% | $521K-12.1% | $593K+1.6% | $584K-53.5% | $1.3M-6.1% | $1.3M |
| Income Tax | $14K-87.3% | $111K-8.3% | $121K+79.1% | $67K-32.7% | $100K+41.3% | $71K+260.2% | $20K | N/A |
| Net Income | -$4.5M-154.2% | $8.4M+129.2% | -$28.8M-220.2% | -$9.0M-509.6% | -$1.5M-22.0% | -$1.2M-5.3% | -$1.1M-92.8% | -$595K |
| EPS (Diluted) | $-1.78-143.4% | $4.10+125.4% | $-16.15 | $-605.49 | $-3054.05 | $-2440.85 | $-1.36 | $-0.82 |
CETX Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'24 | Q3'24 | Q2'24 | Q1'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $47.8M+3.4% | $46.2M-1.0% | $46.7M+5.8% | $44.1M-6.6% | $47.2M+4.3% | $45.3M-6.5% | $48.5M+19.9% | $40.4M |
| Current Assets | $29.0M+1.4% | $28.6M-1.5% | $29.0M+8.8% | $26.7M-6.0% | $28.4M+7.6% | $26.4M-9.8% | $29.3M+12.1% | $26.1M |
| Cash & Equivalents | $5.0M+9.6% | $4.5M+7.4% | $4.2M+8.4% | $3.9M+33.7% | $2.9M+2.9% | $2.8M-46.8% | $5.3M-19.7% | $6.6M |
| Inventory | $6.6M+7.3% | $6.1M-44.8% | $11.1M+59.1% | $7.0M-5.5% | $7.4M-6.8% | $7.9M-9.2% | $8.7M+2.1% | $8.6M |
| Accounts Receivable | $13.1M+3.3% | $12.7M+38.2% | $9.2M-17.5% | $11.2M-3.3% | $11.5M+16.5% | $9.9M+7.5% | $9.2M+26.7% | $7.3M |
| Goodwill | $3.7M0.0% | $3.7M0.0% | $3.7M0.0% | $3.7M-15.4% | $4.4M0.0% | $4.4M0.0% | $4.4M+12.2% | $3.9M |
| Total Liabilities | $39.1M-1.1% | $39.5M-18.0% | $48.2M+23.0% | $39.2M-7.0% | $42.1M+10.8% | $38.0M-5.3% | $40.1M+24.0% | $32.3M |
| Current Liabilities | $23.8M+1.1% | $23.6M-5.4% | $24.9M+34.0% | $18.6M+2.7% | $18.1M-36.9% | $28.7M+4.9% | $27.3M+6.2% | $25.7M |
| Long-Term Debt | $4.6M-51.7% | $9.5M-20.2% | $11.9M-10.4% | $13.3M-38.4% | $21.6M | N/A | $9.9M+156.3% | $3.9M |
| Total Equity | $8.7M+36.1% | $6.4M+510.6% | -$1.6M-133.1% | $4.7M+0.5% | $4.7M-30.6% | $6.8M-12.1% | $7.7M+4.2% | $7.4M |
| Retained Earnings | -$99.4M-8.4% | -$91.7M+8.4% | -$100.1M-40.3% | -$71.4M-6.8% | -$66.8M-2.3% | -$65.3M-1.9% | -$64.1M-3.8% | -$61.8M |
CETX Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'24 | Q3'24 | Q2'24 | Q1'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$3.3M-216.0% | $2.8M+333.2% | -$1.2M+35.8% | -$1.9M-584.2% | $387K+112.3% | -$3.1M-557.3% | $686K+44.2% | $476K |
| Capital Expenditures | $496K+13.8% | $436K-52.9% | $924K+6.5% | $868K+1242.8% | $65K-77.8% | $291K-85.5% | $2.0M+749.5% | -$308K |
| Free Cash Flow | -$3.7M-258.3% | $2.4M+211.3% | -$2.1M+22.4% | -$2.7M-950.7% | $322K+109.4% | -$3.4M-161.1% | -$1.3M-881.6% | $168K |
| Investing Cash Flow | -$1.5M-245.8% | -$428K+57.6% | -$1.0M-18.5% | -$851K-1209.5% | -$65K+83.3% | -$390K+92.0% | -$4.9M-4627.5% | $108K |
| Financing Cash Flow | $3.0M+318.2% | -$1.4M-156.8% | $2.4M+349.6% | $531K+110.4% | $252K-74.7% | $998K-69.9% | $3.3M+1139.3% | -$319K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
CETX Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'24 | Q3'24 | Q2'24 | Q1'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.4%-1.2pp | 44.6%+3.1pp | 41.5%+1.5pp | 40.0%-0.4pp | 40.4%-1.5pp | 42.0%-2.0pp | 44.0%-1.7pp | 45.7% |
| Operating Margin | -3.8%-20.7pp | 16.9%+33.5pp | -16.6%+5.0pp | -21.6%-15.6pp | -6.0%-1.6pp | -4.4%-4.7pp | 0.4%-2.1pp | 2.5% |
| Net Margin | -26.8%-57.5pp | 30.8%+240.0pp | -209.3%-148.1pp | -61.2%-52.6pp | -8.6%-1.4pp | -7.1%+0.6pp | -7.8%-4.1pp | -3.7% |
| Return on Equity | N/A | 130.9% | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -9.7%-27.8pp | 18.1%+79.7pp | -61.6%-41.1pp | -20.5%-17.4pp | -3.1%-0.4pp | -2.7%+0.1pp | -2.8%-1.3pp | -1.5% |
| Current Ratio | 1.220.0 | 1.21+0.0 | 1.17-0.3 | 1.44-0.1 | 1.57+0.6 | 0.92-0.2 | 1.07+0.1 | 1.01 |
| Debt-to-Equity | 0.53-1.0 | 1.48+9.1 | -7.63-10.4 | 2.82-1.8 | 4.60-1.0 | 5.62+4.3 | 1.29+0.8 | 0.53 |
| FCF Margin | 10.2%+1.5pp | 8.7%+24.2pp | -15.5%-19.6pp | 4.1%+2.2pp | 1.9%+22.2pp | -20.3%-16.8pp | -3.5%-4.6pp | 1.1% |
Similar Companies
Frequently Asked Questions
What is Cemtrex's annual revenue?
Cemtrex (CETX) reported $76.5M in total revenue for fiscal year 2025. This represents a 14.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Cemtrex's revenue growing?
Cemtrex (CETX) revenue grew by 14.4% year-over-year, from $66.9M to $76.5M in fiscal year 2025.
Is Cemtrex profitable?
No, Cemtrex (CETX) reported a net income of -$28.1M in fiscal year 2025, with a net profit margin of -36.8%.
What is Cemtrex's earnings per share (EPS)?
Cemtrex (CETX) reported diluted earnings per share of $-210.88 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Cemtrex's EBITDA?
Cemtrex (CETX) had EBITDA of $1.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Cemtrex have?
As of fiscal year 2025, Cemtrex (CETX) had $5.0M in cash and equivalents against $4.6M in long-term debt.
What is Cemtrex's gross margin?
Cemtrex (CETX) had a gross margin of 42.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Cemtrex's operating margin?
Cemtrex (CETX) had an operating margin of 0.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Cemtrex's net profit margin?
Cemtrex (CETX) had a net profit margin of -36.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Cemtrex's free cash flow?
Cemtrex (CETX) generated -$1.8M in free cash flow during fiscal year 2025. This represents a 66.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Cemtrex's operating cash flow?
Cemtrex (CETX) generated $159K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Cemtrex's total assets?
Cemtrex (CETX) had $47.8M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Cemtrex's capital expenditures?
Cemtrex (CETX) invested $1.9M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Cemtrex spend on research and development?
Cemtrex (CETX) invested $2.4M in research and development during fiscal year 2025.
How many shares does Cemtrex have outstanding?
Cemtrex (CETX) had 830,606 shares outstanding as of fiscal year 2025.
What is Cemtrex's current ratio?
Cemtrex (CETX) had a current ratio of 1.22 as of fiscal year 2025, which is considered adequate.
What is Cemtrex's debt-to-equity ratio?
Cemtrex (CETX) had a debt-to-equity ratio of 0.53 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Cemtrex's return on assets (ROA)?
Cemtrex (CETX) had a return on assets of -58.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Cemtrex's Altman Z-Score?
Cemtrex (CETX) has an Altman Z-Score of -0.95, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Cemtrex's Piotroski F-Score?
Cemtrex (CETX) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Cemtrex's earnings high quality?
Cemtrex (CETX) has an earnings quality ratio of -0.01x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Cemtrex cover its interest payments?
Cemtrex (CETX) has an interest coverage ratio of 0.2x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Cemtrex?
Cemtrex (CETX) scores 39 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.